Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,352.00up ₹7.00 (0.52%)BSE ₹1,350.20
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,345.00.
30 Oct: open ₹1,345.00, high ₹1,363.70, low ₹1,345.00
52-week range of traded prices to 30 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,849 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,14,05957.9% delivered
Dr. Reddy's Laboratories share news and announcements
1,702 announcements, routine notices left out, newest first. Page 32 of 35.
Oct 2009
26 Oct · Management
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on October 23, 2009 has appointed Dr. Ashok S Ganguly as an Additional Director on the Board of Directors of the Company with effect from October 23, 2009.23 Oct · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 23, 2009, titled "Dr. Reddy's Q2 FY10 Results, Revenues at Rs.18,368 million, up by 14% EBITDA at Rs.3,797 million, up by 51%, PAT at Rs.2,173 million, up by 106%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 357921 lacs for half year ending on 30-SEP-2009 against Rs. 305720 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 47874 lacs for the half year ending on 30-SEP-2009 against Rs. 17860 lacs for the half year ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 221739 lacs for half year ending on 30-SEP-2009 against Rs. 200168 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 42450 lacs for the half year ending on 30-SEP-2009 against Rs. 30105 lacs for the half year ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 180043 lacs for quarter ending on 30-SEP-2009 against Rs. 157594 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 23985 lacs for the quarter ending on 30-SEP-2009 against Rs. 8664 lacs for the quarter ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 107322 lacs for quarter ending on 30-SEP-2009 against Rs. 92243 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19706 lacs for the quarter ending on 30-SEP-2009 against Rs. 9101 lacs for the quarter ending on 30-SEP-2008.20 Oct · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 20, 2009, titled "Dr. Reddy's joins American Chemicals Society Green Chemistry Institute Pharmaceutical Roundtable". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Oct · Board meeting
Inter alia to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2009.6 Oct · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 06, 2009, titled "Dr. Reddy's launches Strea(TM) C10 and Strea(TM) A15 in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Oct · Allotment of Equity Shares
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that "The Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company on October 5, 2009, to Employees on exercise of their Stock Options. (a) 41,140 equity shares of Rs.5/- each of the Company pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 15,282 equity shares of Rs.5/- each underlying 15,282 ADRs of the Company pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007".
Sep 2009
3 Sep · Allotment of shares/ others
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company on September 3, 2009, to Director/Employees on exercise of their Stock Options. (a) 69,519 equity shares of Rs.5/- each of the Company pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 8,490 equity shares of Rs.5/- each underlying 8,490 ADRs. of the Company pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Aug 2009
26 Aug · Meeting
Dr. Reddy's Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the company held on July 22, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Aug · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated August 13, 2009, titled "Dr. Reddy's launches Strea(TM) Professional in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Aug · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated August 05, 2009, titled "Dr. Reddy's launches FINRID (TM) in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 30, 2009, titled "Dr. Reddy's launches Execare (TM) in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Meeting
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding the outcome of Annual General Meeting held on July 22, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jul · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 21, 2009, titled "Dr. Reddy's Q1 FY10 Results, Revenues at Rs.18,189 million, up by 21% EBITDA at Rs.4,364 million, up by 90%, PAT at Rs.2,445 million, up by 120%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jul · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 114417 lacs for quarter ending on 30-JUN-2009 against Rs. 107925 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 22744 lacs for the quarter ending on 30-JUN-2009 against Rs. 21005 lacs for the quarter ending on 30-JUN-2008.21 Jul · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 177878 lacs for quarter ending on 30-JUN-2009 against Rs. 148126 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 23889 lacs for the quarter ending on 30-JUN-2009 against Rs. 9197 lacs for the quarter ending on 30-JUN-2008.7 Jul · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 07, 2009, titled "Dr. Reddy's Laboratories Limited announces filing of Annual Report on From 20-F". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2009.
Jun 2009
23 Jun · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 23, 2009, titled "Dr. Reddy's launches Bispec(TM) in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jun · Allotment of Equity Shares
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that : "Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Governance & Compensation Committee of the Board of Directors of the Company has allotted 150,058 equity shares of Rs. 5 each of the Company on June 17, 2009, to Directors/ Employees who have exercised their Stock Options. Further, pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Governance & Compensation Committee of the Board of Directors of the Company has allotted 48,435 equity shares of Rs. 5 each underlying 48,435 ADRs of the Company on June 17, 2009, to a Director/ Employees of the Company who have exercised their Stock Options."15 Jun · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 15, 2009, titled "Dr. Reddy's announces strategic alliance with GSK for Emerging Markets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Jun · Meeting
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 7, 2009 to July 11, 2009 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 22, 2009.9 Jun · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 09, 2009, titled "Dr. Reddy's announces ANDA approval of Omeprazole Mg OTC". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
21 May · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 21, 2009, titled "Dr. Reddy's receives approval for Three INDs and announces reorganization of its Drug Discovery Operations". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Grant of Stock Options
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that "The Board of Directors of the Company on May 18, 2009, approved the grant of 9,000 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under "Dr. Reddy's Employees Stock Option Scheme, 2002" and also approved the grant of 9,000 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under "Dr. Reddy's Employees ADR Stock Option Scheme, 2007". Further the Compensation Committee of the Board of Directors of the Company on May 18, 2009 approved the grant of 350,840 stock options, exercisable at par value of Rs.5/- to the employees of the Company under "Dr. Reddy's Employees Stock Option Scheme, 2002" and also approved the grant of 65,600 stock options, exercisable at par value of Rs.5/- to the employees of the Company under "Dr. Reddy's Employees ADR Stock Option Scheme, 2007".18 May · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 104583 lacs for quarter ending on 31-MAR-2009 against Rs. 98887 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 15617 lacs for the quarter ending on 31-MAR-2009 against Rs. 16226 lacs for the quarter ending on 31-MAR-2008.18 May · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 399963 lacs for year ending on 31-MAR-2009 against Rs. 333066 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 56089 lacs for the year ending on 31-MAR-2009 against Rs. 47522 lacs for the year ending on 31-MAR-2008.18 May · Dividend
Dr. Reddy's Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 18, 2009 have recommended a final dividend of 125% i.e. Rs. 6.25 per equity share of Rs. 5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting.18 May · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 18, 2009, titled "Dr. Reddy's FY09 Revenues at Rs.69,441 million; EBITDA at Rs.14,505 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 May · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 679037 lacs for year ending on 31-MAR-2009 against Rs. 491417 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. (91724) lacs for the year ending on 31-MAR-2009 against Rs. 43813 lacs for the year ending on 31-MAR-2008.6 May · Board meeting
Inter-alia to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2009 and recommend dividend, if any, for the financial year 2008-09.
Apr 2009
28 Apr · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 28, 2009, titled "Dr. Reddy's launches Nexret (TM)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Apr · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 22, 2009, titled "Dr. Reddy's launches Redispar (TM) in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Apr · Results
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company will announce and publish the Audited Annual Results of the Company for the year ended March 31, 2009 instead of Unaudited Quarterly Results for the Quarter ended March 31, 2009.
Mar 2009
19 Mar · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 19, 2009, titled "Dr. Reddy's Laboratories realigns Global Generics geography portfolio". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Mar · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 18, 2009, titled "Dr. Reddy's crosses $150 million revenue milestone in Russia & CIS region". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Mar · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 12, 2009, titled "Dr. Reddy's receives favorable summary judgment ruling in the Omeprazole Mg OTC litigation". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Mar · Allotment of Equity Shares
Dr. Reddy's Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option scheme, 2002 the Compensation Committee of the Board of Directors of the Company has allotted 29,888 equity shares of Rs.5 each of the Company on March 09, 2009 to employees who have exercised their Stock Options. Further, pursuant to Dr. Reddy's Employees ADR Stock Option scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 9,752 ADR's of Rs.5 each of the Company on March 09, 2009 to US employees of the Company who have exercised their ADR Stock Options.
Feb 2009
25 Feb · Limited Review Report
Dr. Reddy's Laboratories Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Feb · Disclosure
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that "We have been informed by the promoters/promoter group of the company that pledge on 4,10,000 equity shares of the company held by them, have been released. Accordingly, the percentage of pledged shares has come down from 6.19% to 5.94% of the outstanding share capital of the company as on Febuary 16, 2009." The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).6 Feb · Disclosure
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has been informed by the promoters / promoter group of the Company that they have pledged 10,419,829 equity shares of the Company held by them. This represents 6.19% of the company's outstanding shares as on date. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Feb · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated February 05, 2009, titled "Dr. Reddy's announces five ANDA approvals and Generic product launches in the US Market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
20 Jan · Management
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that Prof. Krishna G. Palepu, non-executive Director on the Board of Directors of the Company has resigned from his position with effect from January 20, 2009. The Board has accepted his resignation with immediate effect and appreciated his contribution to the Company.20 Jan · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 180499 lacs for quarter ending on 31-DEC-2008 against Rs. 119915 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 15916 lacs for the quarter ending on 31-DEC-2008 against Rs. 6226 lacs for the quarter ending on 31-DEC-2007.20 Jan · Business
Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 20, 2009, titled "Dr. Reddy's Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jan · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 95212 lacs for quarter ending on 31-DEC-2008 against Rs. 76370 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 10367 lacs for the quarter ending on 31-DEC-2008 against Rs. 4229 lacs for the quarter ending on 31-DEC-2007.5 Jan · Board meeting
To, interalia consider and take on record the unaudited financial results of the Company for the quarter and nine months ended December 31, 2008.